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Abstract
Background: In the biopharmaceutical industry, Escherichia coli (E. coli) strains are among the most frequently used
bacterial hosts for producing recombinant proteins because they allow a simple process set-up and they are Food
and Drug Administration (FDA)-approved for human applications. Widespread use of E. coli in biotechnology has
led to the development of many different strains, and selecting an ideal host to produce a specific protein of
interest is an important step in developing a production process. E. coli B and K–12 strains are frequently employed
in large-scale production processes, and therefore are of particular interest. We previously evaluated the individual
cultivation characteristics of E. coli BL21 and the K–12 hosts RV308 and HMS174. To our knowledge, there has not
yet been a detailed comparison of the individual performances of these production strains in terms of recombinant
protein production and system stability. The present study directly compared the T7-based expression hosts E. coli
BL21(DE3), RV308(DE3), and HMS174(DE3), focusing on evaluating the specific attributes of these strains in relation
to high-level protein production of the model protein recombinant human superoxide dismutase (SOD). The
experimental setup was an exponential carbon-limited fed-batch cultivation with minimal media and single-pulse
induction.
Results: The host strain BL21(DE3) produced the highest amounts of specific protein, followed by HMS174(DE3)
and RV308(DE3). The expression system HMS174(DE3) exhibited system stability by retaining the expression vector
over the entire process time; however, it entirely stopped growing shortly after induction. In contrast, BL21(DE3)
and RV308(DE3) encountered plasmid loss but maintained growth. RV308(DE3) exhibited the lowest ppGpp
concentration, which is correlated with the metabolic stress level and lowest degradation of soluble protein fraction
compared to both other strains.
Conclusions: Overall, this study provides novel data regarding the individual strain properties and production
capabilities, which will enable targeted strain selection for producing a specific protein of interest. This information
can be used to accelerate future process design and implementation.
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Introduction
The best applicable expression host for an individual
production process is typically determined based on
various characteristics and attributes of the specific re-
combinant protein, like glycosylation pattern or post-
translational modifications. Escherichia coli (E. coli) is by
far the most widely used host organism for biopharma-
ceutical production of simple non-modified heterologous
recombinant proteins with a low number of disulfide
bonds. E. coli expression strains are favored due to their
ability to quickly reach high cell densities in inexpensive
media and their Food and Drug Administration (FDA)-
approved status for human applications [1]. Additionally,
their well-characterized genetics and publicly available
genome sequences [2-4], and the availability of a large
number of cloning vectors and various mutant strains
ensure that E. coli remains a valuable host for recom-
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binant protein production [5]. However, some drawbacks
must be considered when selecting an E. coli expression
system, including the limited ability to build disulfide
bonds, the lack of an efficient secretion system due to
the complexity of the two cell membranes, and the in-
ability to perform posttranslational modifications that
occur with eukaryotic proteins [6,7].
Selection of an appropriate promoter is also a major
step in process design. For high-level recombinant pro-
tein synthesis in E. coli, the promoter must be strong
and inducible, and should exhibit a minimal level of
basal transcriptional activity [7]. The pET system (plas-
mid for expression by T7 RNA polymerase) applied in
the present study meets most of these requirements
[8,9]; however, the resulting strong and high-level pro-
tein expression can overburden the metabolic capacities
of the production host and lead to growth inhibition or
even cessation after a short period of time [10,11].
Therefore, the actual production phase during a process
is very limited. Strong host/vector interactions also con-
tribute to the stress level of the host, resulting in
decreased recombinant protein yields far below the the-
oretical maximum. High-level protein production can
also lead to modifications in catabolism and anabolism,
including adjustments of the energy generating system,
the protein producing system, and cellular fluxes [11,12].
Overall, the cellular reactions caused by recombinant
protein production are similar to the heat shock and
stringent responses of E. coli [12]. Altogether, these
unfavorable conditions and the limitation of cellular
resources caused by high production rates often result
in accumulation of damaged and un- or mis-folded
proteins in the host cell [13]. Inclusion bodies (IB)
sometimes form, depending on the specific folding be-
havior of the protein of interest; even small changes in
the primary structure of a protein can influence its
solubility [14].
Furthermore, in plasmid-based expression systems, the
cellular energy required for plasmid maintenance and
replication may influence the process outcome. In some
cases the applied systems encounter problems with plas-
mid stability, leading to plasmid-free cell populations.
To avoid plasmid-maintenance and stability problems,
genome-based expression systems that integrate the tar-
get gene into the chromosome have been established for
E. coli [15]; however, plasmid-based systems are still fa-
vored in industry because the cloning procedures are
simpler and faster.
The present work focused on evaluating the prominent
and very strong T7 expression system (commercialized
by Novagen), within the most popular E. coli hosts,
using an industrial-like process set-up. Previous compar-
isons of different strains have investigated biomass yield,
growth behavior, or mRNA expression profiles [16-19].
For recombinant processes the impact of recombinant
protein production onto the host metabolism is of also
of great interest, as the host-vector interactions during
such harsh conditions are often complex and unpredict-
able. Here we transformed the B strain BL21(DE3) and
the two K–12 strains HMS174(DE3) and RV308(DE3)
with the pET30a plasmid (Novagen; Germany) encoding
the gene for human superoxide dismutase (SOD, EC
1.15.1.1) [20], and we evaluated their performances in
fully induced fed-batch cultivations. The two K–12
hosts, RV308 a derivative of MG1655 and HMS174 of
W3110, were compared to the well-known BL21 strain.
All three are industrially relevant strains frequently used
in large scale production processes [21]. The model pro-
tein human superoxide dismutase used in this study can
be expressed in soluble form in the cytoplasm of E. coli
[20]. However, strong expression systems and high
amounts of inducer (IPTG) can lead to the accumulation
of both soluble and insoluble SOD (inclusion bodies;
IBs). Therefore, this protein was selected as model pro-
tein and the distribution of the soluble versus the inso-
luble protein form was monitored and used as quality
criteria. We characterized the studied strains in terms of
growth behavior, productivity, product quality (solubil-
ity), and overall system stability. The experiments were
designed to provide valuable information about E. coli
performance in industrial-like processes, which can be
used in future process set-up and design.
Results
Experimental set-up of cultivations
The key objective of this work was to evaluate the im-
pact of T7-based protein expression in three different E.
coli hosts in terms of growth, productivity, product qual-
ity, and system stability. The two K–12 strains RV308
(DE3) (genotype: lacIq-, su-, ΔlacX74, gal, IS II::OP308,
strA, (DE3)) and HMS174(DE3) (genotype: F-, recA1,
hsdR(rK12
- mK12
+ ) (RifR) (DE3)) and the B strain BL21
(DE3) (genotype: F-, dcm, ompT, hsdS(rB- mB-), gal,
(DE3)) were cultivated during the expression of plasmid-
encoded (pET30a) recombinant SOD in glucose-limited
exponential fed-batch cultivations at a growth rate of
0.1 h−1. The following expression systems were used in
this study: E. coli BL21(DE3)(pET30aSOD), E. coli
HMS174(DE3)(pET30aSOD), and E. coli RV308(DE3)
(pET30aSOD). Hereafter, these systems are referred to
as BL21, HMS174, and RV308, respectively. To trigger
very high recombinant gene expression levels, we ap-
plied single-pulse full induction using isopropyl β-D-1-
thiogalactopyranoside (IPTG) at one doubling past the
feed start. In contrast to common industrial processes,
we performed an early induction of recombinant protein
synthesis to allow an elongated observation time of the
hosts during the production phase. Therefore, an expe-
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rimental design was chosen to monitor cellular host
reactions on strong recombinant protein expression
under fed-batch conditions over a period of three gener-
ations (doubling times, 21 hours) in detail. All cultiva-
tions were conducted in triplicate, and samples were
drawn at hourly intervals for comprehensive analysis via
off-line methods, including determination of the optical
density (OD600), cell number, cell viability, cell size by
fluorescence-activated cell sorting (FACS), and system
stability (Koch-plating). Sample aliquots were also stored
for subsequent analyses of product yield, distribution
between the soluble and insoluble protein fraction
(product quality), plasmid copy number (PCN), guano-
sine tetraphosphate (ppGpp) level, and determination of
metabolites (acetate, formate, pyruvate, and glucose) in
the cultivation broth supernatant. The analysis of metab-
olites combined with off-gas analysis of O2 and CO2
also enabled calculation of mass-balances. All of these
analyses were used to characterize the cellular host reac-
tions triggered by recombinant gene expression, and the
SOD production capabilities of the three strains.
Cell growth
The actual glucose yield coefficient (Yx/s) of each strain
was determined during the non-induced phase of the
process. YX/S was calculated with 0.40 g cell dry mass
(CDM) per g glucose for BL21 and RV308, and 0.34 g
CDM per g glucose for HMS174, theoretically yielding
441.5 g CDM each for BL21 and RV308 and 372.3 g
CDM for HMS174 from the total of ~1100 g glucose
provided during the process. This theoretical biomass
yield was compared to the measured CDM of each host.
Analysis of biomass formation and growth rate
Analyses of CDM during the cultivations showed diffe-
rent biomass courses of the three hosts, as well as devia-
tions from the calculated specific CDM after induction
of recombinant protein synthesis (Figure 1A, C and E).
Each strain exhibited growth rate reduction shortly after
induction (Figure 1B, D and F). BL21 and HMS174
exhibited sudden decreases in their growth rates after in-
duction at feed-hour seven, while RV308 maintained
post-induction cellular growth for four hours longer.
Figure 1 Cell dry mass and growth rates. Measured cell dry mass (CDM) (means and standard error of the mean) and the theoretically
achievable CDM for (A) BL21, (C) HMS174, and (E) RV308. The theoretical CDM was calculated with constant yield coefficients of 0.34 g/g for
HMS174 and 0.40 g/g for BL21 and RV308. Measured growth rates of the hosts during the fed-batch phase (means ± standard error of the mean)
are shown for (B) BL21, (D) HMS174, and (F) RV308. Recombinant protein synthesis was induced at feed-hour seven.
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HMS174 did not resume cellular growth; the growth
rate dropped to zero and remained at zero until the end
of the cultivations (Figure 1D). In contrast, growth of
BL21 and RV308 resumed at a later stage of the process
(feed-hour 14; Figure 1B and F). At the end of the
process, BL21 and RV308 had achieved similar CDM
(317 ± 7 and 317 ± 2 g CDM, respectively), while that of
HMS174 was lower (57 ± 1 g CDM). These values were
lower than the calculated total CDM by 28% for both
BL21 and RV308, and 85% for HMS174.
Carbon (C) balances
To elucidate the differences in growth and carbon
utilization of the three strains, C balances were calcu-
lated (Table 1). The elemental composition of E. coli bio-
mass (CH1.77O0.49 N0.24) was derived from literature and
Table 1 Carbon balance of HMS174, RV308, and BL21 cultivations for the entire process and the separate process
phases (non-induced phase, production phase, and end phase)
HMS174 Experiment (0 to 28 h) Phase I (0 to 7 h) Phase II (7 to 16 h) Phase III (16 to 28 h)
g % g % g % g %
Glucose provided 1095.0 50.6 135.3 100.0 197.9 91.1 761. 5 31.3
Glucose consumed 553.8 ± 31.83 135.3 ± 022 180.4 ± 0.93 238.1 ± 31.83
C in consumed glucose C6H12O6 201.4 ± 11.58 49.2 ± 0.08 65.6 ± 0.34 86.6 ± 11.32
C in biomass CH1.77O0.49 N0.24 28.5 ± 0.23 14.2 21.4 ± 0.20 43.4 7.2 ± 0.05 10.9 non-detectable
C in acetate CH3COO
- 8.9 ± 0.64 4.4 non-detectable non-detectable 8.9 ± 0.68 10.2
C in formate HCOO- non-detectable non-detectable non-detectable non-detectable
C in pyruvate C3H3O3 2.4 ± 0.10 1.2 non-detectable 0.1 ± 0.00 0.2 2.3 ± 0.09 2.7
C in carbon dioxide CO2 86.6 ± 2.77 43.0 23.1 ± 1.31 46.9 34.7 ± 1.88 52.9 28.9 ± 0.53 33.4
Sum of C detected 126.5 62.8 44.4 90.3 41.9 64.0 40.1 46.3
C not detected 74.8 37.2 4.8 9.7 23.6 36.0 46.5 53.7
RV308 Experiment (0 to 28 h) Phase I (0 to 7 h) Phase II (7 to 16 h) Phase III (16 to 28 h)
g % g % g % g %
Glucose provided 1103.6 100.0 135.3 100.0 197.1 100.0 771.3 100.0
Glucose consumed 1103.6 ± 0.00 135.3 ± 0.00 197.1 ± 0.00 771.3 ± 0.00
C in consumed glucose C6H12O6 401.3 ± 0.00 49.2 71.7 280.5
C in biomass CH1.77O0.49 N0.24 152.5 ± 0.46 38.0 26.7 54.3 23.2 32.3 102.7 36.6
C in acetate CH3COO
- 0.3 ± 0.04 0.1 non-detectable 0.1 0.1 0.2 0.1
C in formate HCOO- 0.4 ± 0.07 0.1 non-detectable 0.1 0.1 0.3 0.1
C in pyruvate C3H3O3 non-detectable non-detectable non-detectable non-detectable
C in carbon dioxide CO2 190.1 ± 3.51 47.4 19.6 ± 0.21 39.9 40.5 ± 1.59 56.6 130.0 ± 2.24 46.3
Sum of C detected 343.3 85.5 46.3 94.1 63.8 89.0 233.2 83.1
C not detected 58.0 14.5 2.9 5.9 7.9 11.0 47.3 16.9
BL21 Experiment (0 to 28 h) Phase I (0 to 7 h) Phase II (7 to 16 h) Phase III (16 to 28 h)
g % g % g % g %
Glucose provided 1103.8 99.8 135.6 99.8 197.9 99.6 770.6 99.9
Glucose consumed 1101.6 ± 0.01 135.3 ± 0.03 196.8 ± 0.15 769.6 ± 0.11
C in consumed glucose C6H12O6 400.7 ± 0.00 49.2 ± 0.01 71.6 ± 0.05 279.8 ± 0.04
C in biomass CH1.77O0.49 N0.24 152.2 ± 2.02 38.0 24.9 ± 0.03 50.4 14.6 ± 0.46 20.4 112.7 ± 1.56 40.3
C in acetate CH3COO
- 0.6 ± 0.10 0.1 non-detectable 0.3 ± 0.04 0.4 0.3 ± 0.10 0.1
C in formate HCOO- 0.3 ± 0.09 0.0 0.1 ± 0.03 0.1 0.1 ± 0.04 0.1 0.2 ± 0.07 0.1
C in pyruvate C3H3O3 0.1 ± 0.10 0.0 non-detectable non-detectable 0.1 ± 0.05 0.0
C in carbon dioxide CO2 216.5 ± 1.16 54.0 25.5 ± 0.54 51.8 48.2 ± 0.50 67.3 142.8 ± 1.26 51.0
Sum of C detected 369.4 92.1 50.5 102.6 63.1 88.1 256.1 91.5
C not detected 31.3 7.9 −1.3 −2.6 8.5 11.9 23.8 8.5
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applied for all three hosts [22,23]. The uptake of carbon
provided through glucose was compared with the bio-
mass and metabolites produced during the process. In a
completely defined system, all supplied carbon can be
found in components produced during the process. In
addition to the carbon balance of the entire process
(feed-hours 0–28), separate C balances were calculated
for three phases of the process to examine the different
growth kinetics of the three hosts. Phase I was the non-
induced part of the process (feed-hours 0–7), phase II
was the production period (feed-hours 7–16), and phase
III was the final part of the process (feed-hours 16–28).
During phase I, similar results were observed for the
three hosts (Table 1). The carbon provided was mostly
converted to biomass and carbon dioxide, but a small
portion of glucose (below 10%) was not detected in any
specific compounds measured. In phase II (feed-hours
7–16), biomass formation of HMS174 was significantly
reduced; only 11% of C was drained to biomass, 53% to
CO2, and about 36% of C was not assignable to mea-
sured metabolites. For the other two strains, the C bal-
ances did not show large deviations between carbon
provided and detected; the non-assignable carbon frac-
tions (~12%) were only slightly greater after induction
compared to during the non-induced phase. During
phase III (feed-hours 16–28) the situation was even
worse for HMS174; only 31% of the glucose provided
during the feed-phase was consumed, almost 54% of this
carbon could not be assigned to measured metabolites,
and no biomass was produced at all. Therefore, high
concentrations of glucose were present in the fermen-
tation broth of HMS174. In contrast, no residual glucose
was detected in the supernatant of RV308 and BL21 cul-
tivations; thereby the strains were growing according to
the provided feed-regime.
Recombinant superoxide dismutase protein production
Because of the different growth behaviors of the three
strains, protein production was only monitored for the
first nine hours past induction to enable equitable com-
parisons of the specific production capabilities of the
three hosts. Additionally, an end-point sample of each
strain was quantified to further characterize the pro-
cesses, the protein expression properties, and the pro-
teolytic activity in each system.
Protein yield and formation kinetics
The highest specific product (SOD) contents in BL21
and HMS174 were detected at eight hours post-induction
(213 ± 3 and 201 ± 3 mg/g, respectively) (Figure 2A). For
RV308, the highest specific amount (170 ± 3 mg/g) was
measured at seven hours post-induction. At nine hours
after induction, the specific product yields started to
decline for all hosts. The specific recombinant protein
formation rates (qP) behaved similarly for all strains, rising
to maximum values of ~40 mg/g/h at two hours post-
induction, and decreasing to zero within one doubling
time (7 h) of induction (Figure 2B).
Distribution of soluble and insoluble protein
In terms of product quality, all three hosts were compar-
able and produced about 80 mg/g CDM of soluble SOD
Figure 2 Recombinant SOD protein synthesis. (A) Total (IB and soluble) specific recombinant protein yields, (B) specific product formation rate
(qP), (C) insoluble SOD fraction, and (D) soluble fraction of SOD for the three strains (means ± standard error of the mean). Induction of
recombinant protein synthesis was performed at feed-hour 7.
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(Figure 2D). At feed-hour 11 (four hours induced) the
soluble protein fraction of the HMS174 cultivations
started to decline; whereby the protein amount of both
other hosts stayed about constant during the monitored
production phase.
The lowest number of inclusion bodies was detected
during cultivations of RV308, with a maximum of 92 ±
3 mg/g at seven hours post-induction (feed-hour 14)
(Figure 2C). BL21 and RV308 showed similar insoluble
product formation up to feed-hour 11; thereafter a re-
duction of the specific inclusion body production rates
of RV308 was measured. HMS174 and BL21 were simi-
lar in terms of overall inclusion body formation, produ-
cing 133 ± 4 and 139 ± 4 mg/g, respectively, although
HMS174 showed no inclusion body formation for up
to three hours post-induction (Figure 2C). This earlier
start of inclusion body formation of BL21 and RV308
was reflected in higher qP levels shortly after induction
(Figure 2B).
The corresponding percentages of soluble SOD were
approximately 50% for RV308, and 40% each for BL21
and HMS174. Altogether, a decrease of the insoluble
fraction was detected for all three hosts about seven
hours post induction (feed-hour 14) for the K–12 strain
RV308 and eight hours post induction (feed-hour 15)
during the cultivations of the BL21 and HMS174 host
(Figure 2C).
To generally characterize the processes and the hosts’
potential protein degrading and proteolytic activities, the
soluble SOD fractions at the process end (feed-hour 28)
were quantified and compared to those at feed-hour 16.
The results revealed strong declines of specific SOD pro-
ductions, with only 46.6 mg/g for HMS174, 26.2 mg/g
for RV308, and 7.8 mg/g for BL21 at the process end,
compared to approximately 80 mg/g soluble protein at
feed-hour 16. ELISA results of the total protein amounts
of soluble SOD at the end (feed-hour 28) showed reduc-
tions of 62% in BL21 (6.53 g compared to 2.53 g SOD)
and 30% in HMS174 (3.74 g compared to 2.66 g), but an
increase of 11% in RV308 (7.47 g compared to 8.25 g).
Characterization of host cell response to recombinant
protein expression
In this study the differences between the three hosts in
terms of the cells’ responses to recombinant gene expres-
sion were investigated. We analyzed plasmid copy number
(PCN), plasmid stability, cell viability, and cellular stress
level (ppGpp level) [24,25] for each strain, to enable an
in-depth evaluation and comparison.
Plasmid copy number and plasmid retention
Before induction, the PCN were comparable among the
strains. After induction, an increase of the PCN from 40
to nearly 400 plasmids per cell was detected within eight
hours in HMS174. Both other hosts exhibited lesser in-
fluences of induction on plasmid replication, with a
maximal PCN of ~160 measured for BL21 and ~130 for
RV308 (Figure 3A). The percentage of plasmid-bearing
cells was determined by Koch-plating. RV308 and BL21
exhibited strong decreases of plasmid-carrying cells over
time (Figure 3B). In HMS174, 80% of the cells were plas-
mid bearing at the end of the process, while only 20% of
plasmid-carrying cells remained in RV308, and none in
BL21 (Figure 3B).
Cell viability and cell number
Flow cytometry revealed only very low percentages of
dead cells for all hosts. For RV308, the content of dead
cells was always below 1% (Figure 4A). In HMS174 and
BL21, up to 3% dead cells were identified during the in-
duced phase (feed-hours 7–16). Up to 5% dead cells
were detected at the process end in HMS174 cultivations
(Figure 4A), while in BL21, the number of dead cells de-
creased again during the course of cultivation. Flow
cytometric measurements also demonstrated lower cell
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Figure 3 Effects of induction on plasmid-bearing cells. (A) Plasmid copy number per cell during the production phase (means ± standard
error of the mean) and (B) percentage of plasmid-bearing cells before induction (feed-hour 7), after one generation of induction (feed-hour 14),
and after three generations induced (feed-hour 28; end of process) determined by Koch-plating.
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numbers for HMS174 compared to the other two hosts,
especially at the end of the process (Figure 4B).
Quantification of metabolic stress
During the cultivations, we measured the nucleotide
ppGpp, an effector molecule that is correlated to the
host cell metabolic load imposed by recombinant protein
production, and that reflects the metabolic stress level of
the cells [24-26]. BL21 and HMS174 exhibited rapid
rises in ppGpp concentration shortly after induction
(Figure 5). In contrast, RV308 showed no post-induction
change in ppGpp level. The ppGpp level of BL21
decreased again at the end of the cultivations.
Discussion
Cellular growth
The course of CDM and the final process outcome of
the three strains were significantly influenced by the
induction strategy and the individual responses of the
strains to high-level recombinant protein synthesis. Be-
fore induction, all three strains exhibited exponential
growth behavior according to the feed media addition
(glucose) and the individual yield coefficients. After
induction, cell growth was instantly inhibited during cul-
tivations of BL21 and HMS174. In contrast, cell growth
of RV308 was inhibited four hours after induction.
These results indicate a higher metabolic load of BL21
and HMS174, which was supported by the increasing
ppGpp levels in these two strains compared to the con-
stant level observed in RV308. The ppGpp synthesis
pathway of RV308 is considered functional, since this
strain produced higher levels of ppGpp in another ex-
periment under different conditions.
In the later stage of the process, RV308 and BL21 re-
sumed growth, while the growth rate of HMS174
dropped to zero and did not recommence. Plasmid in-
stability and consequent formation of a non-producing
cell population was identified as a reason for the recov-
ery of growth in RV308 and BL21. Koch-plating results
showed decreased plasmid-carrying cells at the process
end, with only 20% of plasmid-bearing cells remaining in
RV308 and none in BL21. However, the analytical
method used tends to underestimate the fraction of
plasmid-carrying cells because producing cells possess
reduced ability to divide or form colonies on agar plates
as they enter a “viable but non-culturable” state [27].
Nevertheless, high plasmid loss clearly occurred in BL21
and RV308, while HMS174 demonstrated very high sys-
tem stability. These results were further confirmed by
low plasmid copy numbers of RV308 and BL21, as this
value represents the average number for the whole cell
population. The changes in cell morphology between
non-growing plasmid-harboring and growing plasmid-
free cells were not sufficiently distinct to enable differen-
tiation via FACS measurement. It is possible that the for-
mation of plasmid-free non-producing cells was due to
plasmid multimer formation, resulting in hampered
distribution of plasmids to daughter cells. Multimer
formation is a recA-dependent phenomenon [28], and
genotyping revealed that BL21 and RV308 are both
recA-positive (recA+), in contrast to HMS174.
Carbon balancing yielded unexpected results; in the
worst-case (phase III of HMS174 cultivations), almost
Figure 4 Flow cytometric measurements of dead and viable cells. Flow cytometric measurements of (A) dead cells and (B) viable cells
during the course of the cultivations (means ± standard error of the mean). Induction of recombinant protein synthesis was performed with IPTG
at feed-hour seven.
Figure 5 Analysis of the nucleotide ppGpp. Levels of ppGpp
were analyzed by HPLC during fed-batch cultivations of E. coli
HMS174, BL21, and RV308 [25]. Data shown are means ± standard
error of the mean. Recombinant protein synthesis was induced with
IPTG at feed-hour seven.
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54% of carbon was not detectable by the applied analytical
methods. Protein precipitation experiments showed a sig-
nificant portion of soluble protein in the supernatant, and
the SDS-PAGE pattern of the supernatant revealed high
similarity to cell lysate patterns (Additional file 1).
Although no quantitative data is available, it is likely that
the missing carbon in the calculated C-balances was
incorporated in cellular protein DNA and RNA released
to the supernatant by cell lysis. The FACS results did not
show significant accumulation of dead cells over the entire
process time (Figure 4A), even in HMS174; however, this
finding does not contradict the assumption of cell lysis, as
the FACS method is based on particle counting and thus
cannot detect a completely lysed cell. Our results showed
that carbon balancing and quantification of missing C
may be a method for indirect quantification of cell lysis.
Cell lysis could be further quantified by measuring protein
or DNA in the supernatant respective of total organic
carbon and nitrogen.
Recombinant protein formation and solubility
The specific amounts of total recombinant protein (in-
cluding both soluble and insoluble SOD) were compar-
able in BL21 and HMS174, while RV308 yielded lower
amounts (Figure 2A). This difference can be attributed
to the significantly reduced levels of SOD accumulated
in inclusion bodies in RV308, as the soluble SOD frac-
tions were similar in all three hosts. A maximum of ap-
proximately 80 mg/g soluble SOD was obtained in all
three strains, indicating a limited cellular capacity for
producing soluble SOD under the given cultivation/in-
duction conditions without any influence of the different
genetic backgrounds of E. coli K–12 or B strains applied
(Figure 2). This finding demonstrated that frequently de-
scribed advantages of E. coli BL21 are limited to batch
cultivations and that the range of host strains which can
be employed in large scale production is significantly
broadened by commonly applied carbon limited fed-
batch cultivation conditions. At the beginning of the
production phase, exclusively soluble SOD was pro-
duced; however, over the course of the experiments,
more and more protein was accumulated in the inso-
luble form as IB. In all tested strains, correct SOD fold-
ing occurred with a rate of approximately zero,
indicating that either the cellular folding machinery be-
came overstrained or essential compounds of the folding
infrastructure were no longer available in sufficient
amounts. Irrespective of the intrinsic sequence features
of SOD that can impact folding behavior, it can be as-
sumed that protease activity partially contributed to the
above-described phenomenon, as soluble protein is more
exposed to proteolysis. At cultivation end (feed-hour 28)
a reduction of the total soluble protein fraction for BL21
and HMS174 in comparison to feed-hour 16 was
identified. This can possibly be connected to a potential
proteolytic activity. Therefore, the optimal process end-
point to achieve maximum yields of the recombinant
product was reached at about one generation (seven to
eight hours) past induction. No such degradation was
identified for RV308 and the amount of total soluble
protein even increased by about 10%. This proposes a
lower proteolytic activity as the already produced soluble
protein stayed approximately constant until the end of
the cultivation.
Conclusions
The present comprehensive comparison of three indus-
trially relevant host strains under production conditions
enabled identification of individual benefits and draw-
backs of each host cell line, as well as weaknesses of the
utilized process conditions. All three hosts were unable
to maintain their growth rate after induction because
the recombinant gene expression rate exceeded the
physiologically tolerable limits. E. coli BL21 and RV308
later recovered their cell growth, likely due to plasmid
loss. In contrast, E. coli HMS174 did not resume cell
growth due to its apparent higher system stability. In
terms of productivity, BL21 and HMS174 produced lar-
ger specific amounts of SOD than RV308; however, all
three strains produced similar amounts of soluble SOD.
Overall, RV308 showed no degradation of already pro-
duced soluble protein, but HMS174 would be the candi-
date of choice concerning plasmid stability and system
integrity. The carbon balancing results revealed signifi-
cant amounts of non-traceable carbon in all strains,
showing that cell lysis is much more pronounced than
expected and possibly explaining the phenomena of pas-
sive diffusion as lysis [29].
In general, apart from plasmid stability, it was surpris-
ing that the differences between the three hosts, espe-
cially between E. coli B and K–12, were not more
pronounced. In particular, RV308 showed high resem-
blance to the behavior of the B strain. This is possibly
connected with the controlled conditions in a bioreactor
with pH-regulation and oxygen supply in contrast to
standard shake flasks, where the different acetate meta-
bolism of the B strain might be beneficial. The difference
in the stability of the plasmid is most likely connected to
the distinct recA genotypes and proposes a possible
knock-out strategy of this gene to enhance plasmid
stability.
Based on the presented results, it can be concluded
that cultivation temperature and induction level exert a
high impact on cellular folding capacity and protein ag-
gregation. The applied conditions, which were close to
standard industrial strategies, clearly triggered extremely
high metabolic load levels and are therefore suboptimal
for achieving the highest possible protein yields. General
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optimization strategies, such as reduction of cultivation
temperature and induction strength, would be applicable
for enhancing the soluble recombinant protein fraction
in all three hosts. For HMS174, the transcription tuning
concept [30] could also be used, while the reduced sys-
tem stability of BL21 and RV308 would interfere with
this optimization approach. The present data should be
taken into consideration in future development of new
recombinant production processes with any of the three
strains (or related hosts). This information will enable
improved process predictability, and thereby also sub-
stantially shorten process development.
Methods
All chemicals were purchased from VWR unless other-
wise stated. Fed-batch cultivations with a growth rate of
0.1 h−1 were performed to evaluate differences in the
responses of three E. coli hosts to recombinant protein
expression. Upon depletion of the glucose from the
batch process, an exponential substrate feed was started
to maintain a constant growth rate of 0.1 h−1 during four
doubling times. Recombinant gene expression was in-
duced by a single pulse of IPTG (20 μmol/g CDM after
one doubling past the feed start).
Bacterial strains and plasmid
Experiments were performed with E. coli HMS174(DE3)
(pET30aSOD), E. coli RV308(DE3)(pET30aSOD), and E.
coli BL21(DE3)(pET30aSOD). RV308 was purchased
from the American Type Culture Collection (ATCC #
31608); BL21(DE3) and HMS174(DE3) from Novagen.
The DE3-derivative of E. coli RV308 was prepared using
the λDE3-lysogenization kit (Novagen, Germany)
according to the manufacturer’s protocol. The three
strains were transformed with the pET30a vector
(Novagen, Germany; pET System manual, 11th edition)
carrying the model protein human Cu/Zn superoxide
dismutase (SOD) (EC 1.15.1.1). This (pET30aSOD) was
derived by subcloning of the sod gene from
(pET11aSOD), described elsewhere [20]. SOD is a highly
soluble 32-kDa protein comprising two homologous
subunits (a 153-amino acid monomer), which is
expressed in the cytoplasm and is nontoxic to the host
cell. The T7 expression system is based on expression of
the RNA polymerase of bacteriophage T7 under control
of the lacUV5 in E. coli [8,9].
Cell cultivation
The minimal medium used for cultivations contained
3 g KH2PO4 and 6 g K2HPO4∙3H2O per liter; these con-
centrations provided the required buffer capacity and
served as sources of P and K. The other components
were added in relation to the theoretical grams of CDM
to be produced (calculated for 22.5 g in batch-phase and
337.5 g CDM in feed-phase, based on the constant glu-
cose yield coefficient YX/S of 0.3 g/g): 0.25 g sodium cit-
rate (trisodium salt∙2H2O; ACROS organics), 0.10 g
MgSO4∙7H2O, 0.02 g CaCl2∙2H2O, 50 μL trace element
solution, and 3 g glucose∙H2O. The trace element solu-
tion was prepared in 5 N HCl and included 40 g/L
FeSO4∙7H2O, 10 g/L MnSO4∙H2O, 10 g/L AlCl3∙6H2O,
4 g/L CoCl2 (Fluka), 2 g/L ZnSO4∙7H2O, 2 g/L
Na2MoO2∙2H2O, 1 g/L CuCl2∙2H2O, and 0.5 g/L H3BO3.
We also added 4 mg CuCl2∙2H2O and 3.2 mg
ZnSO4∙7H2O per g CDM. To accelerate initial growth of
the population, the complex component yeast extract
(0.15 g per g theoretical CDM) was added to the min-
imal medium to obtain the batch medium. Eight liters of
minimal media were prepared for the feeding phase,
according to the amount of biological dry matter to be
produced (337.5 g); phosphate salts were again added
per liter. Nitrogen level was maintained by adding 25%
ammonium hydroxide solution (w/w) (MERCK) for
pH control.
The cells were grown in a 20-L (14-L working volume,
4-L batch volume) computer-controlled bioreactor
(MBR; Wetzikon, CH) equipped with standard control
units (Siemens PS7, Intellution iFIX). The pH was
maintained at 7.0 ± 0.05 by addition of 25% ammonium
hydroxide solution (w/w) (MERCK), the temperature
was set to 37°C ± 0.5°C. To avoid oxygen limitation, the
dissolved oxygen level was stabilized at above 30% satur-
ation using stirrer speed and aeration rate control.
Foaming was suppressed by addition of 0.5 mL antifoam
(PPG 2000, Sigma Aldrich) per liter media. To ensure
reproducible processes and data, three replicate culti-
vations were conducted for each strain. Mean values,
including standard error of the mean, were used for rep-
licate characterization.
For inoculation, a deep-frozen (−80°C) working cell bank
vial was thawed, and 1 mL (optical density OD600 = 1) was
aseptically transferred to the bioreactor with 30 mL
physiologic salt solution. Feeding was started when the
culture entered stationary phase. A fed-batch regime with
an exponential substrate feed was used to provide a
constant growth rate of 0.1 h−1 over four doubling times.
The substrate feed was controlled by increasing pump
speed according to the exponential growth algorithm, X =
X0 ∙ e
μt, with superimposed feedback control of weight
loss in the substrate tank. Expression system induction
was performed by adding isopropyl-β-D-thiogalactoside
(IPTG) (GERBU Biotechnik, Germany) to the reactor at
20 μmol IPTG per g calculated CDM (360 g CDM).
Sample preparation
Optical density at 600 nm was measured with a spectro-
photometer (Amersham Biosciences Ultrospec 500 pro).
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CDM was determined by centrifugation of 10 mL of cell
suspension. The supernatant was transferred to an
Eppendorf vial, frozen at −20°C, and analyzed by high-
performance liquid chromatography (1100 HPLC, Agilent
Technologies) using an Aminex HPX-87H ion exclusion
column (Biorad), 0.01 N H2SO4 (20°C and 0.45 mL/mi-
nute) as mobile phase and an UV/visible-light (Knauer)
and refractive index detectors (Beckmann).
The cells were washed with 7 mL distilled water,
resuspended, and transferred to a pre-dried and -
weighed beaker, which was then dried at 105°C for
24 h and re-weighed. For the determination of the nu-
cleotide ppGpp, samples were prepared as previously
described [25], and quantified by ion-pair reversed-
phase HPLC.
Determination of plasmid-bearing cells by Koch-plating
Plasmid-containing cells were determined by cultivation
of bacterial cells using the plasmid-borne antibiotic re-
sistance for selection. Colony forming units (cfu) were
counted after 24 h of cultivation on nutrient broth agar
plates containing 50 mg/L kanamycin to select for cells
containing the vector. To confirm that plasmid-carrying
cells over-produced recombinant protein, we also deter-
mined the cfu after recombinant gene induction by
IPTG (200 mg/L) on selective plates.
Flow cytometry
Total cell number (TCN) and number of dead cells (DC)
were determined by spiking an aliquot of the OD600
sample with a known quantity of fluorescent latex
counting beads (Becton Dickinson), and staining with
fluorescent dyes. The total cell number was recalculated
based on the number of hits and the ratio between gated
cells and gated counting beads.
Flow cytometry was performed with a FACS Calibur
(Becton Dickinson) four-color flow cytometer equipped
with a 488-nm laser and the standard filter setup. The
CellQuestTM Pro (version 4.1) software package was
used for data acquisition and analysis. For preparation
of 10 mL staining solution, we mixed 9985 μL sterile
filtered 1× PBS buffer (DULBECCO, Biochrom AG),
5 μL Tween20 (ACROS Chemicals), and 50 μL
propidium iodide stock solution (1 mg/mL in distilled
water; Becton Dickinson). This solution was aliquoted
into FACS-tubes, 500 μL each. For determination of
TCN via flow cytometry, 25 μL of the OD600 sample
(1:101 or 1:201 dilution) was added to the staining solu-
tion in the FACS-tube. These dilution steps resulted in
a counting rate of between 3000 and 6000 events per
second. TCN was determined via ratiometric counting,
taking into account the number of added counting
beads, the ratio of sample per counting bead, and the
sample volume and dilution factors according to the
following equation:
TCN ¼ Cell−quantity regionð Þ
Bead−quantity regionð Þ
 bead−concentration μlð Þ
sample−volume μlð Þ  dilution−factor
Cell viability was determined based on the dye-
discharging capacity of living cells, using a staining
protocol with a simple live/dead discrimination via PI
[31]. Propidium iodide binds to double-strand DNA, but
cannot penetrate the intact cell membrane of E. coli.
Bacterial cells showing PI fluorescence (Ex = 535 nm,
Em = 617 nm) can be assumed to be dead, but morpho-
logically intact. The number of dead cells was calculated
by the ratio of total cell number and PI-positive cells.
Viable cell number (VCN) was calculated as
VCN ¼ TCN− TCNDC100
Product analysis
The recombinant protein was quantified via SOD-ELISA
[32], and the ratio between soluble protein and inclusion
bodies was determined by SDS-PAGE as previously
described [33].
On-line measurements
To determine base consumption, ammonia consumption
was measured by recording the changes in weight. The
O2 and CO2 contents in the outlet air were determined
using a Hartmann and Braun Advanced Optima gas
analyzer [34,35].
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